Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Polycystic ovary syndrome affects health and can be hard to diagnose, with treatments ranging from drugs to herbal remedies.

APIs' stability is influenced by crystalline forms, pressure, and water.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Antiandrogens block male hormones and are not safe during pregnancy.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Hypertrichosis involves excessive hair growth and needs careful diagnosis and treatment, considering its psychological effects.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Tamoxifen effectively treats gynecomastia without causing impotence.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Low-dose oral minoxidil effectively treats female hair loss with good safety.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Certain Dibenzo derivatives may help treat prostate cancer.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.